by Merz Branding | Mar 4, 2025 | Uncategorized
February 28, 2025 Nordic Pharma, Inc., a subsidiary of Nordic Group B.V., announced today a poster presentation at SECO 2025 being held from February 26 – March 2 in Atlanta, Georgia. Mile Brujic, OD, FAAO of Premier Vision Group will present this poster on Novel...
by Merz Branding | Oct 23, 2024 | Uncategorized
October 17, 2024 Nordic Pharma, Inc., a subsidiary of Nordic Group B.V., launched LACRIFILL Canalicular Gel, a novel therapy for dry eye in the U.S. in April and will continue its introduction to leading ophthalmologists during AAO 2024. LACRIFILL Canalicular Gel is a...
by Nordic Pharma | Mar 15, 2021 | Uncategorized
March 12, 2021 Amring Pharmaceuticals Inc. announced an agreement with Amzell B.V. for the commercial rights to a leading clinical-stage program that will bring critical and accessible therapy for patients in need. Read more
by Nordic Pharma | Dec 2, 2020 | Uncategorized
December 2, 2020 Amring Pharmaceuticals Inc., a generic pharmaceutical company, announced the acquisition of the global rights to LYSTEDA® (tranexamic acid), a first-in-class, non-hormonal therapy indicated specifically for treatment of women with cyclic heavy...
Recent Comments